Study S001087

Effectiveness of Pharmacologic, Surgical, and Dietetic Weight Loss Methods on Lifespan in Patients With Metabolic Syndrome: a Comparative Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06410352
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 220
Start: 2024-03-01
Primary completion: 2025-09-30
Lead sponsor: University Medical Center, Kazakhstan
Conditions: Metabolic Syndrome
Interventions: DRUG:Semaglutide, Empagliflozin; PROCEDURE:Minigastric bypass; DIETARY_SUPPLEMENT:Analimentary detoxication; BEHAVIORAL:Ramadan fast's weight loss
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Weight [Baseline, 24 weeks]
Body mass index [Baseline, 24 weeks]
Fat mass [Baseline, 24 weeks]
Fat free mass [Baseline, 24 weeks]
blood insulin level [Baseline, 24 weeks]
systolic/diastolic Blood presure [Baseline, 24 weeks]
Fasting blood glucose [Baseline, 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.